Evidence map›Paper›PMID 40299516›Full record

ArticleBiomedicines2025

Molecular Detection and Clinical Impact of

Yuma Ita-Balta, Alice Zegarra-Adanaque, Johany Sanchez-Guillen, Miguel Farfán-Delgado, Carlos Ortiz-Castro, Alexis Germán Murillo Carrasco, Alejandro Miranda Pinto, Cecilia Manrique-Sam

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Challenges and Prospects for Eradication ofPathogens (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuma Ita-BaltaEscuela de Postgrado, Universidad Católica de Santa María, Arequipa 04013, Peru.
Alice Zegarra-AdanaqueEscuela de Medicina Humana, Facultad de Medicina Humana, Universidad Católica de Santa María (UCSM), Arequipa 04013, Peru.
Johany Sanchez-GuillenEscuela de Medicina Humana, Facultad de Medicina Humana, Universidad Católica de Santa María (UCSM), Arequipa 04013, Peru.
Miguel Farfán-DelgadoEscuela de Medicina Humana, Facultad de Medicina Humana, Universidad Católica de Santa María (UCSM), Arequipa 04013, Peru.
Carlos Ortiz-CastroClínica Arequipa, Arequipa 04013, Peru.
Alexis Germán Murillo CarrascoImmunology and Cancer Research Group (IMMUCA), OMICS, Lima 15001, Peru.ORCID 0000-0002-7372-2608
Alejandro Miranda PintoEscuela de Medicina Humana, Facultad de Medicina Humana, Universidad Católica de Santa María (UCSM), Arequipa 04013, Peru.
Cecilia Manrique-SamEscuela de Medicina Humana, Facultad de Medicina Humana, Universidad Católica de Santa María (UCSM), Arequipa 04013, Peru.

Funding

Universidad Católica de Santa María RESOLUTION No. 29002-R-2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gastric diseasesHelicobacter pylorihistopathologymolecular detectionPeruvirulence genes

Identifiers

PMID40299516
PMCPMC12025056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.